Hyperphosphatemia

Novel Binder Lowers Phosphate with Fewer Pills

Novel Binder Lowers Phosphate with Fewer Pills

By

In a study, PA21 was as efficacious as sevelamer carbonate, but patients taking PA21 had a lower pill burden and better adherence.

Elevated Phosphorus May Increase Death Risk

Elevated Phosphorus May Increase Death Risk

By

Researchers observed the association among individuals with serum phosphorus levels measured after fasting for 12 or more hours.

Hospitalization Costs Lower with Ferric Citrate

Hospitalization Costs Lower with Ferric Citrate

By

Use is associated with fewer hospitalizations versus sevelamer carbonate and calcium acetate.

Phosphorus Control Using PTH Tested

Phosphorus Control Using PTH Tested

By

In mice with and without CKD, phosphorus levels decreased by an average of 35% by 6 hours after injection with long-acting PTH.

Lower Phosphorus, Higher Protein Intake Improve Survival

Lower Phosphorus, Higher Protein Intake Improve Survival

By

Protein levels found to modify the effect of serum phosphorus with mortality in hemodialysis patients.

No Clinically Relevant Changes in Vitamin D with PA21

No Clinically Relevant Changes in Vitamin D with PA21

By

Researchers compared the novel iron-based phosphate binder with sevelamer.

Team-Focused Approach Improves Phosphorus Control

Team-Focused Approach Improves Phosphorus Control

By

In a study, nurses and technicians educated groups of hemodialysis patients about phosphate binders.

Multi-Prong Approach Has Little Effect on Phosphorus Control

Multi-Prong Approach Has Little Effect on Phosphorus Control

By

Researchers tested an intervention that included an educational fair, phosphorus group social, and staff education on phosphate binders.

Limiting Phosphorus Additives Aids Phosphatemia Control

Limiting Phosphorus Additives Aids Phosphatemia Control

By

Researchers observed reduced phosphorus levels in HD patients whose diet restricted intake of phosphorus additives.

Phosphorus Changes Affect Dialysis Patient Mortality Risk

By

Declines in serum phosphorus over time may improve survival.

Higher PTH and Dietary Protein Intake Hikes Hyperphosphatemia Risk

By

Worsening or resistant hyperphosphatemia may be an under-appreciated consequence of secondary hyperparathyroidism.

Phosphate Binders Offer No Short-Term Mortality Benefit

By

Calcium-based and non-calcium-based binder use were associated with similar death risks.

Limiting Phosphorus Additives in Foods Lowers Serum Phosphorus

By

Levels declined significantly from 7.2 to 5.0 mg/dL, data show.

Vascular Calcification Linked to Lower Phosphate Clearance

By

Vascular calcification contributes to increased cardiovascular risk in dialysis patients.

Oxidative Stress May Be Why High Phosphorus Ups Mortality

By

New findings are consistent with those from previous animal studies.

Novel Iron-Based Binder Has Long-Term Efficacy

By

PA21 comparable in safety and efficacy to sevelamer carbonate out to 52 weeks, study finds.

Fasting Phosphorus Levels Are a Stronger Mortality Predictor

Fasting Phosphorus Levels Are a Stronger Mortality Predictor

By

Serum levels vary throughout the day, and higher phosphorus intake exaggerates the early afternoon rise in serum phosphorus.

Race May Affect Phosphorus-Mortality Link in CKD Patients

By

New findings raise questions "on the generalizability of previous research studies to the clinic setting," researchers conclude.

High Phosphorus Ups Dialysis Patient Death Risk Regardless of Age

By

Low phosphorus increases all-cause and cardiovascular mortality only among the elderly.

Women's Phosphorus Levels Affected by Estrogen

By

Phosphorus levels are lower in postmenopausal women on estrogen replacement therapy.

Calcium-Based Phosphate Binders Up Death Risk

By

Patients who take phosphate binders may be at a 22% higher risk of death that those who take other non-calcium based treatments.

Phosphate Binders Improve Dialysis Patient Survival

By

Use of the agents is associated with a 29% and 22% decreased risk of all-cause and cardiovascular mortality.

Food Additives May Hinder Phosphorus Control in CKD Patients

By

A high proportion of top-selling grocery items contain phosphorus additives, and consumption may be encouraged by their lower cost.

Dialysis Patient Death Risk Lower with Sevelamer

By

It significantly decreased cardiovascular and all-cause mortality compared with calcium carbonate.

Dialysis Patients Struggle to Restrict Dietary Phosphorus

Dialysis Patients Struggle to Restrict Dietary Phosphorus

By

The increasing popularity of processed convenience foods could be a factor.

Heart Abnormality Tied to High Dietary Phosphorus Intake

By

Consuming too much phosphorus increases the risk of left ventricular hypertrophy in women, study finds

Intradialytic High Protein Meals May Correct Low Albumin

By

Combined with use of a binder, this approach raised serum albumin while maintaining target phosphorus levels.

Low BMI, Lipid Abnormalities Linked to High FGF-23

By

Factors unrelated to mineral metabolism may contribute to the association between high FGF-23 and death in dialysis patients.

High Phosphorus Levels Increase Renal Failure Risk

By

Researchers made the discovery in a study of individuals with normal kidney function.

Hyperphosphatemia Raises Proteinuria Risk in CKD Patients

By

Proteinuria also is linked to high cholesterol.

Sign Up for Free e-newsletters